Publications by authors named "Judy E Garber"

100Publications

Histopathologic features of breast cancer in Li-Fraumeni syndrome.

Mod Pathol 2020 Jul 7. Epub 2020 Jul 7.

Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-020-0610-4DOI Listing
July 2020

Reply to S. Takamizawa et al.

J Clin Oncol 2020 Aug 9;38(23):2700-2701. Epub 2020 Jun 9.

Nadine Tung, MD; Michele R. Hacker, ScD; and Judy E., Beth Israel Deaconess Medical Center, Boston, MA Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.20.01190DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402997PMC
August 2020

Premenopausal Plasma Osteoprotegerin and Breast Cancer Risk: A Case-Control Analysis Nested within the Nurses' Health Study II.

Cancer Epidemiol Biomarkers Prev 2020 Jun 10;29(6):1264-1270. Epub 2020 Apr 10.

Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-19-1154DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269832PMC
June 2020

Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers.

Cancer 2020 01 3;126(2):271-280. Epub 2019 Oct 3.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32540DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003745PMC
January 2020

One step forward, two steps backward.

Genet Med 2020 02 3;22(2):441-442. Epub 2019 Oct 3.

Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41436-019-0660-5DOI Listing
February 2020

Genetic Testing for Breast Cancer Susceptibility Should Be Offered before Unilateral Abdominally Based Free Flap Breast Reconstruction.

Plast Reconstr Surg 2019 07;144(1):12-20

Boston, Mass. From the Harvard Plastic Surgery Combined Residency Program; the Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute; Harvard Medical School; and the Division of Plastic Surgery, Brigham and Women's Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PRS.0000000000005693DOI Listing
July 2019

Genotype-phenotype associations among panel-based TP53+ subjects.

Genet Med 2019 11 20;21(11):2478-2484. Epub 2019 May 20.

Department of Medical Oncology, Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41436-019-0541-yDOI Listing
November 2019

Trans-counseling: A case series of transgender individuals at high risk for BRCA1 pathogenic variants.

J Genet Couns 2019 06 24;28(3):708-716. Epub 2019 Jan 24.

Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jgc4.1046
Publisher Site
http://dx.doi.org/10.1002/jgc4.1046DOI Listing
June 2019

Atypical ductal hyperplasia in men with gynecomastia: what is their breast cancer risk?

Breast Cancer Res Treat 2019 May 21;175(1):1-4. Epub 2019 Jan 21.

Division of Surgical Oncology, Massachusetts General Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-05117-4DOI Listing
May 2019

Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy.

J Clin Oncol 2018 11 21;36(31):3134-3143. Epub 2018 Sep 21.

Cristina Cruz and Judith Balmaña, Vall d'Hebron Hospital; Cristina Cruz, Alba Llop-Guevara, Joaquín Arribas, Ana Vivancos, Violeta Serra, and Judith Balmaña, Vall d'Hebron Institute of Oncology; José A. Pérez Fidalgo, Ana Lluch, Joaquín Arribas, and Violeta Serra, Centro de Investigación Biomédica en Red; Joaquín Arribas, Institució Catalana de Recerca i Estudis Avançats, Barcelona; José A. Pérez Fidalgo and Ana Lluch, Hospital Clínico de Valencia, Valencia; Cristian Fernández, Carmen Kahatt, Carlos M. Galmarini, Arturo Soto-Matos, Vicente Alfaro, and Aitor Pérez de la Haza, PharmaMar, Madrid; Silvia Antolin, Complejo Universitario Hospitalario La Coruña, La Coruña; Rafael Lopez, Complejo Hospitalario Universitario Santiago de Compostela, Santiago de Compostela, Spain; Judy E. Garber, Dana Farber Cancer Institute; Nadine M. Tung, Beth Israel Deaconess Medical Center; José Baselga and Steven J. Isakoff, Massachusetts General Hospital Cancer Center, Boston, MA; Banu K. Arun, MD Anderson Cancer Center, Houston, TX; Melinda L. Telli, Stanford University School of Medicine, Stanford, CA; Susan M. Domchek, University of Pennsylvania, Philadelphia, PA; and Linda Vahdat, Weill Cornell Medicine, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.6558DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209089PMC
November 2018

Breast Cancer Surgical Risk Reduction for Patients With Inherited Mutations in Moderate Penetrance Genes.

JAMA Surg 2018 12;153(12):1145-1146

Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamasurg.2018.2493DOI Listing
December 2018

BRCA1/2 testing: therapeutic implications for breast cancer management.

Br J Cancer 2018 07 5;119(2):141-152. Epub 2018 Jun 5.

Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0127-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048046PMC
July 2018

Mixing Mutation Location With Carcinogen Exposure: A Recipe for Tissue Specificity in BRCA2-Associated Cancers?

J Natl Cancer Inst 2018 09;110(9):925-926

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djy047DOI Listing
September 2018

Towards Prevention of Breast Cancer: What Are the Clinical Challenges?

Cancer Prev Res (Phila) 2018 05 16;11(5):255-264. Epub 2018 Apr 16.

Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-16-0254DOI Listing
May 2018

Differences in TP53 Mutation Carrier Phenotypes Emerge From Panel-Based Testing.

J Natl Cancer Inst 2018 08;110(8):863-870

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djy001DOI Listing
August 2018

A counseling framework for moderate-penetrance colorectal cancer susceptibility genes.

Genet Med 2018 11 1;20(11):1324-1327. Epub 2018 Mar 1.

Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/gim.2018.12DOI Listing
November 2018

A comparison of cancer risk assessment and testing outcomes in patients from underserved vs. tertiary care settings.

J Community Genet 2018 Jul 18;9(3):233-241. Epub 2017 Nov 18.

Center for Cancer Genetics and Prevention, Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave DA 1122, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12687-017-0347-z
Publisher Site
http://dx.doi.org/10.1007/s12687-017-0347-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002308PMC
July 2018

Managing hereditary breast cancer risk in women with and without ovarian cancer.

Gynecol Oncol 2017 07 25;146(1):205-214. Epub 2017 Apr 25.

Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, MA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2017.04.013DOI Listing
July 2017

Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study.

J Clin Oncol 2017 Apr 13;35(11):1179-1188. Epub 2017 Feb 13.

Signe Borgquist and Judy E. Garber, Dana-Farber Cancer Institute, Harvard Medical School; Anita Giobbie-Hurder, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute; Richard D. Gelber, IBCSG Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, T.H. Chan Harvard School of Public Health, and Frontier Science and Technology Research Foundation; Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation; Meredith M. Regan, IBCSG Statistical Center, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA; Signe Borgquist, Lund University, Lund, Sweden; Thomas P. Ahern, University of Vermont, Burlington, VT; Marco Colleoni and Aron Goldhirsch, IBCSG and European Institute of Oncology, Milan, Italy; István Láng, IBCSG and National Institute of Oncology, Budapest, Hungary; Marc Debled, Institut Bergonié, Bordeaux, France; Bent Ejlertsen, Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark; Roger von Moos, Cantonal Hospital Graubuenden, Chur; Swiss Group for Clinical Cancer Research and IBCSG; Manuela Rabaglio, IBCSG Coordinating Center and Inselspital, Bern; Beat Thürlimann, Breast Center St. Gallen, Kantonsspital, St. Gallen; Swiss Group for Clinical Cancer Research and IBCSG, Bern, Switzerland; Ian Smith, The Royal Marsden Hospital, London, United Kingdom; and Alan S. Coates, IBCSG and University of Sydney School of Public Health, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.3116DOI Listing
April 2017

THE GORDON WILSON LECTURE EVOLUTION OF CLINICAL CANCER GENETICS.

Authors:
Judy E Garber

Trans Am Clin Climatol Assoc 2016;127:127-139

BOSTON, MASSACHUSETTS.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216520PMC
January 2016

Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.

Breast Cancer Res Treat 2016 12 12;160(3):393-410. Epub 2016 Oct 12.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-4003-9DOI Listing
December 2016

Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing.

J Clin Oncol 2016 12 30;34(34):4071-4078. Epub 2016 Sep 30.

Judith Balmaña, Hospital Vall d'Hebron and Universitat Autònoma de Barcelona, Barcelona, Spain; Laura Digiovanni, Susan M. Domchek, and Katherine L. Nathanson, University of Pennsylvania, Philadelphia, PA; Pragna Gaddam, Michael F. Walsh, Vijai Joseph, Zsofia K. Stadler, Kenneth Offit, and Mark E. Robson, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Judy E. Garber, Dana-Farber Cancer Institute, Boston, MA; and Fergus J. Couch, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.4316DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562435PMC
December 2016

Reply to S.M. Sorscher and M.J. Hall et al.

J Clin Oncol 2016 12 31;34(34):4187-4188. Epub 2016 Oct 31.

Nadine M. Tung, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; and Judy E. Garber, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.1022DOI Listing
December 2016

Counselling framework for moderate-penetrance cancer-susceptibility mutations.

Nat Rev Clin Oncol 2016 09 14;13(9):581-8. Epub 2016 Jun 14.

Clinical Genetics Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue; and the Weill Cornell Medical College, 1300 York Avenue, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2016.90DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513673PMC
September 2016

CANCER. The cancer predisposition revolution.

Science 2016 May;352(6289):1052-3

Sage Bionetworks, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.aag0832DOI Listing
May 2016

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.

J Clin Oncol 2016 May 14;34(13):1460-8. Epub 2016 Mar 14.

Nadine Tung, Beth Israel Deaconess Medical Center; Nancy U. Lin, Eric P. Winer, and Judy E. Garber, Dana-Farber Cancer Institute; Nadine Tung, Nancy U. Lin, Eric P. Winer, and Judy E. Garber, Harvard Medical School, Boston, MA; and John Kidd, Brian A. Allen, Nanda Singh, Richard J. Wenstrup, and Anne-Renee Hartman, Myriad Genetic Laboratories, Inc., Salt Lake City, UT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.0747DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872307PMC
May 2016

The Effect of Atorvastatin on Breast Cancer Biomarkers in High-Risk Women.

Cancer Prev Res (Phila) 2016 05 23;9(5):379-84. Epub 2016 Feb 23.

Department of Medicine, University of Vermont, Burlington, Vermont.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-15-0300DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965880PMC
May 2016

Statin Use and Breast Cancer Risk in the Nurses' Health Study.

Cancer Epidemiol Biomarkers Prev 2016 Jan;25(1):201-6

Departments of Surgery and Biochemistry, University of Vermont College of Medicine, Burlington, Vermont.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-15-0654DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4842011PMC
January 2016

Cancer Survivorship Care: An Opportunity to Revisit Cancer Genetics.

J Clin Oncol 2016 Feb 28;34(6):539-41. Epub 2015 Dec 28.

Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.5375DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872029PMC
February 2016

A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer.

Cancer Epidemiol Biomarkers Prev 2016 Jan 4;25(1):193-200. Epub 2015 Dec 4.

Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina. Cancer Prevention, Detection, and Control Research Program, Duke Cancer Institute, Durham, North Carolina. Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia.

View Article

Download full-text PDF

Source
http://cebp.aacrjournals.org/content/25/1/193.full.pdf
Web Search
http://cebp.aacrjournals.org/cgi/doi/10.1158/1055-9965.EPI-1
Publisher Site
http://dx.doi.org/10.1158/1055-9965.EPI-15-0649DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713268PMC
January 2016

Population-Wide Screening for Germline BRCA1 and BRCA2 Mutations: Too Much of a Good Thing?

J Clin Oncol 2015 Oct 17;33(28):3092-5. Epub 2015 Aug 17.

Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2015.60.8596
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.60.8596DOI Listing
October 2015

PARP inhibitors in the management of breast cancer: current data and future prospects.

BMC Med 2015 Aug 13;13:188. Epub 2015 Aug 13.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12916-015-0425-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535298PMC
August 2015

TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer.

J Clin Oncol 2015 Jun 6;33(17):1902-9. Epub 2015 Apr 6.

Steven J. Isakoff, Lei He, Darrel R. Borger, Dianne M. Finkelstein, Paula D. Ryan, Paul E. Goss, and Leif W. Ellisen, Massachusetts General Hospital Cancer Center; Steven J. Isakoff, Erica L. Mayer, Lei He, Karen Krag, Steven E. Come, Darrel R. Borger, Dianne M. Finkelstein, Judy E. Garber, Paula D. Ryan, Eric P. Winer, Paul E. Goss, and Leif W. Ellisen, Harvard Medical School; Erica L. Mayer, Judy E. Garber, and Eric P. Winer, Dana-Farber Cancer Institute; Steven E. Come, Beth Israel Deaconess Medical Center, Boston; Karen Krag, Massachusetts General Hospital/North Shore Cancer Center, Danvers, MA; Tiffany A. Traina, Memorial Sloan Kettering Cancer Center, New York, NY; Lisa A. Carey, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Hope S. Rugo, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Minetta C. Liu, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC; Vered Stearns, The Johns Hopkins University School of Medicine and The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Kirsten Timms, Myriad Genetics; and Anne-Renee Hartman, Myriad Genetic Laboratories, Salt Lake City, UT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.6660DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451173PMC
June 2015

BRCA1 haploinsufficiency for replication stress suppression in primary cells.

Nat Commun 2014 Nov 17;5:5496. Epub 2014 Nov 17.

1] Harvard Medical School, Boston, Massachusetts 02115, USA [2] Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/ncomms6496
Publisher Site
http://dx.doi.org/10.1038/ncomms6496DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243249PMC
November 2014

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.

Authors:
Paolo Peterlongo Jenny Chang-Claude Kirsten B Moysich Anja Rudolph Rita K Schmutzler Jacques Simard Penny Soucy Rosalind A Eeles Douglas F Easton Ute Hamann Stefan Wilkening Bowang Chen Matti A Rookus Marjanka K Schmidt Frederieke H van der Baan Amanda B Spurdle Logan C Walker Felicity Lose Ana-Teresa Maia Marco Montagna Laura Matricardi Jan Lubinski Anna Jakubowska Encarna B Gómez Garcia Olufunmilayo I Olopade Robert L Nussbaum Katherine L Nathanson Susan M Domchek Timothy R Rebbeck Banu K Arun Beth Y Karlan Sandra Orsulic Jenny Lester Wendy K Chung Alex Miron Melissa C Southey David E Goldgar Saundra S Buys Ramunas Janavicius Cecilia M Dorfling Elizabeth J van Rensburg Yuan Chun Ding Susan L Neuhausen Thomas V O Hansen Anne-Marie Gerdes Bent Ejlertsen Lars Jønson Ana Osorio Cristina Martínez-Bouzas Javier Benitez Edye E Conway Kathleen R Blazer Jeffrey N Weitzel Siranoush Manoukian Bernard Peissel Daniela Zaffaroni Giulietta Scuvera Monica Barile Filomena Ficarazzi Frederique Mariette Stefano Fortuzzi Alessandra Viel Giuseppe Giannini Laura Papi Aline Martayan Maria Grazia Tibiletti Paolo Radice Athanassios Vratimos Florentia Fostira Judy E Garber Alan Donaldson Carole Brewer Claire Foo D Gareth R Evans Debra Frost Diana Eccles Angela Brady Jackie Cook Marc Tischkowitz Julian Adlard Julian Barwell Lisa Walker Louise Izatt Lucy E Side M John Kennedy Mark T Rogers Mary E Porteous Patrick J Morrison Radka Platte Rosemarie Davidson Shirley V Hodgson Steve Ellis Trevor Cole Andrew K Godwin Kathleen Claes Tom Van Maerken Alfons Meindl Andrea Gehrig Christian Sutter Christoph Engel Dieter Niederacher Doris Steinemann Hansjoerg Plendl Karin Kast Kerstin Rhiem Nina Ditsch Norbert Arnold Raymonda Varon-Mateeva Barbara Wappenschmidt Shan Wang-Gohrke Brigitte Bressac-de Paillerets Bruno Buecher Capucine Delnatte Claude Houdayer Dominique Stoppa-Lyonnet Francesca Damiola Isabelle Coupier Laure Barjhoux Laurence Venat-Bouvet Lisa Golmard Nadia Boutry-Kryza Olga M Sinilnikova Olivier Caron Pascal Pujol Sylvie Mazoyer Muriel Belotti Marion Piedmonte Michael L Friedlander Gustavo C Rodriguez Larry J Copeland Miguel de la Hoya Pedro Perez Segura Heli Nevanlinna Kristiina Aittomäki Theo A M van Os Hanne E J Meijers-Heijboer Annemarie H van der Hout Maaike P G Vreeswijk Nicoline Hoogerbrugge Margreet G E M Ausems Helena C van Doorn J Margriet Collée Edith Olah Orland Diez Ignacio Blanco Conxi Lazaro Joan Brunet Lidia Feliubadalo Cezary Cybulski Jacek Gronwald Katarzyna Durda Katarzyna Jaworska-Bieniek Grzegorz Sukiennicki Adalgeir Arason Jocelyne Chiquette Manuel R Teixeira Curtis Olswold Fergus J Couch Noralane M Lindor Xianshu Wang Csilla I Szabo Kenneth Offit Marina Corines Lauren Jacobs Mark E Robson Liying Zhang Vijai Joseph Andreas Berger Christian F Singer Christine Rappaport Daphne Geschwantler Kaulich Georg Pfeiler Muy-Kheng M Tea Catherine M Phelan Mark H Greene Phuong L Mai Gad Rennert Anna Marie Mulligan Gord Glendon Sandrine Tchatchou Irene L Andrulis Amanda Ewart Toland Anders Bojesen Inge Sokilde Pedersen Mads Thomassen Uffe Birk Jensen Yael Laitman Johanna Rantala Anna von Wachenfeldt Hans Ehrencrona Marie Stenmark Askmalm Åke Borg Karoline B Kuchenbaecker Lesley McGuffog Daniel Barrowdale Sue Healey Andrew Lee Paul D P Pharoah Georgia Chenevix-Trench Antonis C Antoniou Eitan Friedman

Cancer Epidemiol Biomarkers Prev 2015 Jan 21;24(1):308-16. Epub 2014 Oct 21.

Sheba Medical Center, Tel Aviv, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-14-0532DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294951PMC
January 2015

Addressing sexual dysfunction after risk-reducing salpingo-oophorectomy: effects of a brief, psychosexual intervention.

J Sex Med 2015 Jan 14;12(1):189-97. Epub 2014 Oct 14.

Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jsm.12713DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304978PMC
January 2015

Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers.

Breast Cancer Res Treat 2014 Nov 14;148(2):397-406. Epub 2014 Oct 14.

Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania School of Medicine, 2 Blockley Hall, 423 Guardian Drive, Philadelphia, PA, 19104-6021, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-014-3134-0
Publisher Site
http://dx.doi.org/10.1007/s10549-014-3134-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224991PMC
November 2014

Parent decision-making around the genetic testing of children for germline TP53 mutations.

Cancer 2015 Jan 15;121(2):286-93. Epub 2014 Sep 15.

Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29027DOI Listing
January 2015

Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.

Cancer 2015 Jan 3;121(1):25-33. Epub 2014 Sep 3.

Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Medicine, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29010DOI Listing
January 2015

Women's concerns about the emotional impact of awareness of heritable breast cancer risk and its implications for their children.

J Community Genet 2015 Jan 7;6(1):55-62. Epub 2014 Aug 7.

Georgetown Lombardi Comprehensive Cancer Center, 3300 Whitehaven Street, NW, Suite 4100, Washington, DC, 20007, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12687-014-0201-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286561PMC
January 2015

Outcome of triple negative breast cancer: comparison of sporadic and BRCA1-associated cancers.

Breast Cancer Res Treat 2014 Jul 18;146(1):175-82. Epub 2014 May 18.

Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA, 02215, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-2995-6DOI Listing
July 2014

Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.

Hum Mutat 2014 Jun;35(6):654-62

Division of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/humu.22559DOI Listing
June 2014

Decisional outcomes of maternal disclosure of BRCA1/2 genetic test results to children.

Cancer Epidemiol Biomarkers Prev 2013 Jul;22(7):1260-6

Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-13-0198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703861PMC
July 2013

Distress and the parenting dynamic among BRCA1/2 tested mothers and their partners.

Health Psychol 2014 Aug 24;33(8):765-73. Epub 2013 Jun 24.

Cancer Prevention & Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1037/a0033418DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883806PMC
August 2014

Prevalence of germline TP53 mutations in HER2+ breast cancer patients.

Breast Cancer Res Treat 2013 May 12;139(1):193-8. Epub 2013 Apr 12.

Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-012-2375-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280061PMC
May 2013

Multiplex genetic testing for cancer susceptibility: out on the high wire without a net?

J Clin Oncol 2013 Apr 4;31(10):1267-70. Epub 2013 Mar 4.

University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2012.46.9403
Publisher Site
http://dx.doi.org/10.1200/JCO.2012.46.9403DOI Listing
April 2013